ClinConnect ClinConnect Logo
Search / Trial NCT06593847

Multisite Virtual Reality Intervention for Speech Anxiety

Launched by BOSTON UNIVERSITY CHARLES RIVER CAMPUS · Sep 9, 2024

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how well a virtual reality (VR) program can help people who have anxiety about public speaking. Researchers want to understand if a person's general positive outlook on life (called "trait positive affectivity") can predict how successful they will be in overcoming their speech anxiety through exposure therapy, which is a type of treatment that gradually exposes people to their fears. They will also explore if factors like self-confidence, hope, and optimism play a role in this process.

To participate in this trial, you need to be between 18 and 70 years old, currently enrolled at a university that is part of the study, and comfortable using a computer or touch screen device. Additionally, you should have a certain level of speech anxiety as measured by a specific questionnaire. If you qualify and decide to join, you will engage with the VR program designed to help reduce your anxiety about speaking in public. This study is currently recruiting participants, and it's a great opportunity for those who want to manage their speech anxiety with modern technology.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Self-report of 18 - 70 years of age
  • Current student at a participating University
  • Ability to read English to provide informed consent
  • Familiarity with a computer keyboard and mouse or a touch screen device (e.g. phone, tablet).
  • For Phase 2: speech anxiety scale score of ≥ 18 on the Personal Report of Communication Apprehension, Public Speaking Subscale (PRCA-PS)
  • Exclusion Criteria:
  • Previous participation (i.e., no participant may take the survey more than once).

About Boston University Charles River Campus

Boston University Charles River Campus is a prominent academic institution dedicated to advancing health and science through innovative research and education. As a sponsor of clinical trials, the campus leverages its extensive resources and interdisciplinary expertise to facilitate groundbreaking studies that aim to improve patient outcomes and contribute to the understanding of various medical conditions. With a commitment to ethical research practices and collaboration with healthcare professionals, Boston University Charles River Campus plays a vital role in translating scientific discoveries into clinical applications that benefit communities locally and globally.

Locations

Austin, Texas, United States

Tucson, Arizona, United States

Boston, Massachusetts, United States

Carbondale, Illinois, United States

Sydney, New South Wales, Australia

Penrith, New South Wales, Australia

Boston, Massachusetts, United States

Reading, Pennsylvania, United States

Bently, Western Australia, Australia

Pokfulam, Hong Kong, China

Marburg, Hesse, Germany

Rotterdam, South Holland, Netherlands

Utrecht, , Netherlands

Patients applied

0 patients applied

Trial Officials

Michael Otto, PhD

Principal Investigator

Boston University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported